Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Eisai
Woman and Man Max 99 years
Eisai Limited
Update Il y a 4 ans
A Multi-centre, Randomised, Double-blind, Placebo- and Entacapone-controlled, Parallel Group Study of the Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients with Motor Fluctuations
To compare the efficacy of one dose strength (4 mg) of E2007 with that of placebo on motor function in patients with Parkinson's disease (PD) who are on optimised and stabilised therapy and experience...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Eisai Limited
Update Il y a 4 ans
A phase II open label single-arm study of E7389 in patients with locally advanced or metastatic breast cancer, previously treated with anthracycline, taxane, and capecitabine therapy, refractory to the last prior therapy for their disease
To evaluate the efficacy and safety of E7389 in patients with locally advanced or metastatic breast cancer who have received anthracycline, taxane, and capecitabine as prior therapy, and are refractor...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Eisai Ltd
Update Il y a 4 ans
A Phase 1b/2 trial studying how well lenvatinib works in treating children and adolescents with different types of cancer that are not responding to treatment or have reappeared following an initial recovery
Cohort 1 (Single-Agent Dose-Finding) Identify the recommended dose (RD) of lenvatinib as a single agent in children and adolescents with relapsed or refractory solid malignant tumors Cohort 2 (Sin...
Country
None
organs
None
Specialty
None
More information
Woman and Man Max 99 years
Eisai Limited
Update Il y a 4 ans
A randomized, multi-centre, double-blind study, to compare the efficacy and safety of zonisamide and carbamazepine as monotherapy, in newly diagnosed partial epilepsy
To assess the efficacy of zonisamide compared to carbamazepine when given as monotherapy to newly diagnosed subjects with partial seizures by assessment of 26 weeks seizure free rate.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Eisai Limited
Update Il y a 4 ans
A double-blind, randomised, placebo-controlled, multi-centre study to assess the efficacy and safety of adjunctive zonisamide in myoclonic seizures associated with idiopathic generalised epilepsy. Estudio en doble ciego, aleatorizado, controlado con placebo y multicéntrico, dirigido a evaluar la eficacia y la seguridad del tratamiento adyuvante con zonisomida en las crisis mioclónicas asociadas a la epilepsia generalizada idiopática
The objective of this trial is to assess the efficacy of adjunctive zonisamide in IGE in reducing the frequency of myoclonic seizures in subjects with continuing seizures despite treatment with one or...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Eisai Ltd
Update Il y a 4 ans
A Randomized, Double-blind, Phase 2 Trial to assess how safe and how efficacious Lenvatinib is at two different starting doses (18 mg vs. 14 mg QD) when it is given in Combination with Everolimus (5 mg once a day ) in patients with Renal cancer that have already had one VEGF-Targeted Treatment Ensayo de fase 2, aleatorizado y doble ciego para evaluar la seguridad y la eficacia de lenvatinib en dos dosis iniciales diferentes (18 mg y 14 mg una vez al día) cuando se administra en combinación con everolimus (5 mg una vez al día) en pacientes con cáncer renal después de un tratamiento previo dirigido contra el VEGF
To assess whether a starting dose of lenvatinib 14 mg in combination with everolimus 5 mg once daily (QD) will provide comparable efficacy (based on objective response rate [ORR]at 24 weeks[ORR24W]) w...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Eisai Limited
Update Il y a 4 ans
A Study on the Effect of E5501 (study drug) in Adults with Chronic Immune Thrombocytopenia
Core Study To demonstrate that the efficacy of E5501 (in addition to standard of care) is superior to placebo (in addition to standard of care) for the treatment of adult subjects with chronic immune...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Eisai Limited
Update Il y a 4 ans
Phase II, Multicenter, Open-label, Single Arm Trial to Evaluate the Safety and Efficacy of Oral E7080 in Medullary and Iodine-131 Refractory, Unresectable Differentiated Thyroid Cancers, Stratified by Histology
In patients with medullary thyroid cancer [MTC] or radioiodine (131I) refractory/resistant differentiated thyroid cancer[DTC]: Determine the effect of E7080 on the objective response rate (ORR) bas...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Eisai Limited
Update Il y a 4 ans
Open Label Extension Study Following Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess Efficacy and Safety of Adjunctive Zonisamide in Primary Generalized Tonic-Clonic Seizures
The objective of this study is to assess the long-term safety of zonisamide in subjects with primary generalized tonic-clonic seizures (PGTCS).
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman
Between 18 years
and 99 years
Eisai Medical Research Inc.
Update Il y a 4 ans
Eisai E7389-G000-301 : Essai de phase 3 randomisé comparant l’efficacité de 2 chimiotérapies par eribulin ou par capécitabine chez des patientes ayant un cancer du sein. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions]
l'objectif de cet essai est de comparer l'efficacité de 2 chimiotérapies par eribulin ou par capécitabine chez des patientes ayant un cancer du sein.
Country
France
organs
Sein
Specialty
Chimiothérapie
Essai clos aux inclusions
More information
Previous
1
2
3
4
5
6
7
8
9
Next